DrTrust launches ECG Pen for monitoring cardiovascular activity from home

Dr Trust, a home health-tech space brand, on Friday said it has launched ECG Pen which will help patients monitor their cardiovascular activities from home and share it with physicians, thus facilitating timely medical intervention in urgent situations.

The device enables detection of common aberrations in cardiovascular rhythm like atrial fibrillation and even third-degree heart blocks which can remain clinically silent for years,Saurabh Goyal, Executive Director of Nureca Pvt Ltd, which owns the Dr Trust brand, said in a statement here.

"We are driving the case for far-reaching adoption of effective and affordable cardiovascular telemedicine solutions powered by the advantages of Internet of Things (IoT) through our Dr Trust ECG Pen home monitoring device," he further said.

"Powered by a patented sensor technology, Dr Trust ECG Pen can connect cardiovascular surveillance from home settings to physicians for continued and comprehensive care, thus facilitating timely medical intervention in urgent situations," he said.

Explaining how Dr Trust ECG Pen leverages telemedicine and IoT, Goyal said, "Dr Trust ECG Pen can help identify cardiovascular disease with high precision in real time, thus saving thousands of precious lives.It enables patients to track their readings on the smart phone and share them with their doctor, along with live ECG reports, anytime from anywhere."